Cargando…

Construction of SARS-CoV-2 spike-pseudotyped retroviral vector inducing syncytia formation

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is handled in biosafety level 3 (BSL-3) facilities, whereas the antiviral screening of pseudotype virus is conducted in BSL-2 facilities. In this study, we developed a SARS-CoV-2 spike-pseudotyped virus based on a semi-replication-competen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Se Yeong, Kim, Do Woo, Jung, Yong Tae
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2022
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8942147/ https://www.ncbi.nlm.nih.gov/pubmed/35322356 http://dx.doi.org/10.1007/s11262-022-01890-z

Ejemplares similares

Improved Coinfection with Amphotropic Pseudotyped Retroviral Vectors
por: Wu, Yuehong, et al.
Publicado: (2009)

Unique Aggregation of Retroviral Particles Pseudotyped with the Delta Variant SARS-CoV-2 Spike Protein
por: Petersen, Jennifer D., et al.
Publicado: (2022)

The Mechanism and Consequences of SARS-CoV-2 Spike-Mediated Fusion and Syncytia Formation
por: Rajah, Maaran Michael, et al.
Publicado: (2022)

Syncytia formation by SARS‐CoV‐2‐infected cells
por: Buchrieser, Julian, et al.
Publicado: (2020)

Syncytia formation by SARS‐CoV‐2‐infected cells
por: Buchrieser, Julian, et al.
Publicado: (2021)

Sequences in the cytoplasmic tail of SARS-CoV-2 Spike facilitate expression at the cell surface and syncytia formation
por: Cattin-Ortolá, Jérôme, et al.
Publicado: (2021)

SARS‐CoV‐2 Alpha, Beta, and Delta variants display enhanced Spike‐mediated syncytia formation
por: Rajah, Maaran Michael, et al.
Publicado: (2021)

The Use of Retroviral Pseudotypes for the Measurement of Antibody Responses to SARS Coronavirus
por: Temperton, Nigel James
Publicado: (2009)

Optimized Pseudotyping Conditions for the SARS-COV-2 Spike Glycoprotein
por: Johnson, Marc C., et al.
Publicado: (2020)

Development of Zika Virus E Variants for Pseudotyping Retroviral Vectors Targeting Glioblastoma Cells
por: Grunwald, Vivien, et al.
Publicado: (2023)

Anti-Fungal Drug Anidulafungin Inhibits SARS-CoV-2 Spike-Induced Syncytia Formation by Targeting ACE2-Spike Protein Interaction
por: Ahamad, Shahzaib, et al.
Publicado: (2022)

Syncytia Formation in Oncolytic Virotherapy
por: Burton, Chase, et al.
Publicado: (2019)

Pyroptosis of syncytia formed by fusion of SARS-CoV-2 spike and ACE2-expressing cells
por: Ma, Huabin, et al.
Publicado: (2021)

Computationally prioritized drugs inhibit SARS-CoV-2 infection and syncytia formation
por: Serra, Angela, et al.
Publicado: (2021)

SARS-CoV-2 requires cholesterol for viral entry and pathological syncytia formation
por: Sanders, David W, et al.
Publicado: (2021)

Stability of Retroviral Vectors Against Ultracentrifugation Is Determined by the Viral Internal Core and Envelope Proteins Used for Pseudotyping
por: Kim, Soo-hyun, et al.
Publicado: (2017)

The Integral Membrane Protein ZMPSTE24 Protects Cells from SARS-CoV-2 Spike-Mediated Pseudovirus Infection and Syncytia Formation
por: Shilagardi, Khurts, et al.
Publicado: (2022)

368. Pseudotyping HIV Vector with the Spike Envelope Protein of SARS-CoV for Studying Viral Tropism, Immunology and Gene Therapy Applications
Publicado: (2004)

Engineering a serum-resistant and thermostable vesicular stomatitis virus G glycoprotein for pseudotyping retroviral and lentiviral vectors
por: Hwang, Bum-Yeol, et al.
Publicado: (2013)

Efficient Pseudotyping of Different Retroviral Vectors Using a Novel, Codon-Optimized Gene for Chimeric GALV Envelope
por: Mirow, Manuela, et al.
Publicado: (2021)

Role of the Spike Glycoprotein of Human Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Virus Entry and Syncytia Formation
por: Qian, Zhaohui, et al.
Publicado: (2013)

Cholesterol supplementation during production increases the infectivity of retroviral and lentiviral vectors pseudotyped with the vesicular stomatitis virus glycoprotein (VSV-G)
por: Chen, Yong, et al.
Publicado: (2009)

Neutralization of SARS-CoV-2 spike pseudotyped virus by recombinant ACE2-Ig
por: Lei, Changhai, et al.
Publicado: (2020)

Comprehensive and systemic optimization for improving the yield of SARS-CoV-2 spike pseudotyped virus
por: Fu, Xinping, et al.
Publicado: (2020)

Neutralization Assay with SARS-CoV-1 and SARS-CoV-2 Spike Pseudotyped Murine Leukemia Virions
por: Zheng, Yue, et al.
Publicado: (2020)

Neutralization assay with SARS-CoV-1 and SARS-CoV-2 spike pseudotyped murine leukemia virions
por: Zheng, Yue, et al.
Publicado: (2021)

Fusion assays for screening of fusion inhibitors targeting SARS-CoV-2 entry and syncytia formation
por: Chan, Shiu-Wan
Publicado: (2022)

Syncytia in Fungi
por: Mela, Alexander P., et al.
Publicado: (2020)

Protocol and Reagents for Pseudotyping Lentiviral Particles with SARS-CoV-2 Spike Protein for Neutralization Assays
por: Crawford, Katharine H. D., et al.
Publicado: (2020)

Testing of the inhibitory effects of loratadine and desloratadine on SARS-CoV-2 spike pseudotyped virus viropexis
por: Hou, Yajing, et al.
Publicado: (2021)

Dexamethasone inhibits SARS-CoV-2 spike pseudotyped virus viropexis by binding to ACE2
por: Zhang, Yongjing, et al.
Publicado: (2021)

SARS-CoV-2 Syncytium under the Radar: Molecular Insights of the Spike-Induced Syncytia and Potential Strategies to Limit SARS-CoV-2 Replication
por: Ali, Hashim, et al.
Publicado: (2023)

Syncytia formation during SARS-CoV-2 lung infection: a disastrous unity to eliminate lymphocytes
por: Lin, Liangyu, et al.
Publicado: (2021)

Changes within the P681 residue of spike dictate cell fusion and syncytia formation of Delta and Omicron variants of SARS-CoV-2 with no effects on neutralization or infectivity
por: Kuzmina, Alona, et al.
Publicado: (2023)

Cytoplasmic Tail Truncation of SARS-CoV-2 Spike Protein Enhances Titer of Pseudotyped Vectors but Masks the Effect of the D614G Mutation
por: Chen, Hsu-Yu, et al.
Publicado: (2021)

A sensitive retroviral pseudotype assay for influenza H5N1‐neutralizing antibodies
por: Temperton, Nigel J., et al.
Publicado: (2007)

Structural insight into SARS-CoV-2 neutralizing antibodies and modulation of syncytia
por: Asarnow, Daniel, et al.
Publicado: (2021)

The stability of envelope-pseudotyped lentiviral vectors
por: Dautzenberg, Iris J. C., et al.
Publicado: (2020)

An optimised method for the production of MERS-CoV spike expressing viral pseudotypes
por: Grehan, K., et al.
Publicado: (2015)

Pseudotyped Vesicular Stomatitis Virus for Functional Analysis of Sars Coronavirus Spike Protein
por: Fukushi, Shuetsu, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_f1c2po2te02fgrajlvfirf7m8d